ALBRIOZA Approved as a Treatment for ALS in Canada with Conditions
June 15, 2022
Amylyx Pharmaceuticals, Inc announced that ALBRIOZA approved as a treatment for ALS in Canada with conditions by Health Canada.
Read More >>
ALS Society
of Manitoba
La Société
Manitobaine de la SLA
The Archive
Month: June 2022
Learn More
The Archive
- November 2024
- October 2024
- September 2024
- July 2024
- May 2024
- March 2024
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
Discover
>
TOP